Toradol (Ketorolac) in Breast Surgery to Reduce Pain & Opioid Use

• Status: Recruiting
• Trial end date: 2023-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to investigate whether perioperative single-dose administration of ketorolac (Toradol) can reduce post-operative pain after breast surgery, thereby decreasing post-operative opioid use.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Carilion Clinic
• Treatments: Ketorolac; Ketorolac Tromethamine

Criteria

Inclusion Criteria:

• Patient consents to study

• Adult females needing breast reconstruction or breast reduction (day surgeries)

Exclusion Criteria:

• Patients with known kidney disease

• Patient does not consent

• patients with history of bleeding disorder, peptic ulcer disease, renal disease, blood thinners use, bariatric surgery and any other contraindications of Toradol use

• patients currently taking aspirin

• pregnant women (not standard to operate on this population anyway)